Boughey, Judy C. https://orcid.org/0000-0003-3820-3228
Yu, Hongmei
Dugan, Catherine Lu
Piltin, Mara A.
Postlewait, Lauren
Son, Jennifer D.
Edmiston, Kirsten K.
Godellas, Constantine
Lee, Marie C.
Carr, Michael J.
Tonneson, Jennifer E.
Crown, Angelena
Lancaster, Rachel B.
Woriax, Hannah E.
Ewing, Cheryl A.
Chau, Harrison S.
Patterson, Anne K.
Wong, Jasmine M.
Alvarado, Michael D.
Yang, Rachel L.
Chan, Theresa W.
Sheade, Jori B.
Ahrendt, Gretchen M.
Larson, Kelsey E.
Switalla, Kayla
Tuttle, Todd M.
Tchou, Julia C.
Rao, Roshni
Tamirisa, Nina
Singh, Puneet
Gould, Rebekah E.
Terando, Alicia
Sauder, Candice
Hewitt, Kelly
Chiba, Akiko
Esserman, Laura J.
Mukhtar, Rita
Article History
First Online: 3 August 2023
Disclosures
: Dr. Esserman is an uncompensated board member of the Quantum Leap Healthcare Collaborative, which sponsors the I-SPY TRIAL; she also reports that she is on the Blue Cross Medical Advisory Panel, is paid for travel, and is given an honorarium for her time; she leads an investigator-initiated vaccine trial for high-risk ductal carcinoma in situ funded by Merck through the University of California San Francisco. There are no conflicts related to this manuscript. Dr. Singh reports funding to the institution for the trial through trial sponsors, specifically Foundation for the National Institutes of Health and ACRI. Dr. Tchou is a consultant for BD. Dr. Boughey receives research support paid to her institution from Eli Lilly and SymBioSis and is on a DSMB for CairnsSurgical. She has received honoraria for speaking for PER, PeerView, EndoMag and contributed a chapter to UpToDate.